— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

Balance Sheet Trends

Total Assets
$230M -4.1% ▼
5Y CAGR: -15.8%
Total Liabilities
$213M +11.2% ▲
5Y CAGR: -7.2%
Shareholders Equity
-$34M -2651.9% ▼
Cash & Investments
$17M +108.6% ▲
5Y CAGR: +116.8%
Total Debt
$155M +0.0% ▲
5Y CAGR: -6.9%
Net Debt
$138M +1767.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2025FY2026
— Assets —
Cash$1M$2M$3M$8M$17M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$1M$2M$3M$8M$17M
Net Receivables$70M$48M$31M$23M$30M
Inventory$70M$67M$42M$32M$25M
Other Current Assets$7M$7M$7M$22M$8M
Total Current Assets$148M$124M$83M$86M$84M
Property, Plant & Equip.$200M$139M$131M$129M$124M
Goodwill & Intangibles$106M$29M$14M$18M$14M
Long-Term Investments$45M$0$0$0$0
Other Non-Current Assets$4M$3M$8M$7M$8M
Total Non-Current Assets$355M$171M$154M$154M$146M
Total Assets$503M$295M$237M$239M$230M
— Liabilities —
Accounts Payable$48M$16M$15M$8M$8M
Short-Term Debt$33M$46M$1M$0$970K
Deferred Revenue$1M$919K$3M$0$5M
Other Current Liabilities$20M$17M$19M$22M$0
Total Current Liabilities$102M$79M$37M$30M$22M
Long-Term Debt$189M$10M$125M$0$154M
Other Non-Current Liab.$10M$98M$801K$162M-$13M
Total Non-Current Liabilities$198M$108M$126M$162M$142M
Total Liabilities$300M$187M$163M$192M$213M
— Equity —
Common Stock$29K$30K$30K$37K$38K
Retained Earnings$39M-$59M-$139M-$205M-$244M
Accumulated OCI-$1M-$586K-$39M$0$0
Total Stockholders Equity$203M$108M$35M$1M-$34M
Total Liabilities & Equity$503M$295M$237M$193M$230M
— Key Metrics —
Total Debt$221M$153M$126M$0$155M
Net Debt$220M$152M$123M-$8M$138M
Total Investments$45M$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms